Personalized Nanomedicines for Leukemia Patients

Tomasz Skorski

BCR/ABL-PI-3k-ROS pathway induce genomic instability ....

Leukaemia

Hematology and hematologic malignancies Pathology

Irving L. Weissman

HSC Diversity, in aging, ontogeny, and transformation

Leukaemia

Marina Y Konopleva

Hypoxia-Selective Kinase Inhibitors for Leukemia Therapy

Leukaemia

Hematology and hematologic malignancies Pathology

Tait D Shanafelt

Predicting Clinical Outcome After Traditional and Ibrutinib-based Therapy In Chronic Lymphocytic Leukemia

Leukaemia

Hematology and hematologic malignancies

Everett Meyer

T-cell monitoring and immunotherapy for treating graft-versus-host disease

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Marc Nicklaus

In Silico Screening for Cancer Targets

Trachea, bronchus and lung Leukaemia

Hematology and hematologic malignancies Pathology

Andrew Weng

Regulation of Leukemia Stem Cell Activity by Signaling through PKC[theta]

Leukaemia

Javier Adachi

Identification of the Gastro-Intestinal Microbiota in Patients with Leukemia at MD Anderson, in Texas and INEN, Peru

Leukaemia

Hematology and hematologic malignancies Pathology

Joseph L Wiemels

Genome-Wide Association Study of Childhood Leukemia by Hispanic Status

Leukaemia

Hematology and hematologic malignancies Pediatric oncology or childhood cancer